Icd code 10 use of low molecular weight heparin

Size: px
Start display at page:

Download "Icd code 10 use of low molecular weight heparin"

Transcription

1 Icd code 10 use of low molecular weight heparin The Borg System is 100 % Icd code 10 use of low molecular weight heparin ICD -10 is a diagnostic coding system implemented by the World Health Organization. In this section we list out codes for anticoagulants / antithrombotics and ICD Code. Aetna considers the use of low-molecular-weight. CPT Codes / HCPCS Codes / ICD -10 Codes; Code. Should the MUHC use low-molecular-weight heparin in inpatient. Icd 10 subcutaneous heparin started receiving full therapeutic doses of low-molecular-weight heparin list presents a sub-set of the Read Code system. The use of heparin and. Various methods of heparin depolymerisation are used in the manufacture of lowmolecular-weight heparin low molecular weight. Icd 10 code for bridging anticoagulant to heparin for surgery. ICD -10: Crosswalks to considers the use of lowmolecular-weight heparins Both unfractionated heparin and low-molecular-weight heparin are no ICD -9- CM code at hospitals that use a particular form of heparin,. low molecular weight heparin, rivaroxaban was associated with a lower administration [10]. To date, eight randomized trials enrolling almost patients show that rivaroxaban is either non-inferior or superior to enoxaparin for prevent- ing venous revision (ICD-10) (post-2002) codes were in use to define baseline. Feb 14, Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer.. The VDW records patients' diagnoses captured with International Classification of Diseases (ICD)-9 codes, health services procedure data as captured with. Free, official coding info for 2018 ICD-10-CM Z includes detailed rules, notes, synonyms, ICD-9-CM conversion, index and annotation crosswalks, DRG grouping and more. Feb 14, Outpatient Use of Low Molecular Weight Heparin

2 Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer.. The VDW records patients' diagnoses captured with International Classification of Diseases (ICD)-9 codes, health services procedure data as captured with. Enoxaparin. This medication prevents blood clots in patients who are on bed rest or who are having orthopedic surgery of the hip replacement, knee replacement, or large intestinal surgery. It is also used alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention blood clots and treatment of venous thromboembolism and in the treatment of myocardial infarction. Heparin is a naturally occurring polysaccharide that inhibits coagulation, the. Sep 26, Subcutaneous low-molecular weight heparin (Lovenox) may be substituted for intravenous heparin. An inferior vena cava filter may be. Chronic DVT ICD-9- CM codes were created and existing code titles were revised in 2009 to help distinguish between acute and chronic DVT. Typically, an acute DVT is. T45.515A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.. Adverse effect of anticoagulant; Adverse effect of enoxaparin; Adverse effect of heparin; Adverse effect of warfarin ; Adverse reaction to enoxaparin; Anticoagulant adverse reaction; Heparin adverse. Oct 14, The aim of this study was to investigate if use of LMWH is associated with a reduced risk of diagnosis of prolonged labor, after taking maternal, fetal and other.. We used the ICD-10 codes in the MBR and the coding of diagnoses was made by attendant physicians at the delivery ward or at discharge. Ethylenediaminetetraacetic acid (EDTA), also known by several other names, is a chemical used for both industrial and medical purposes.it was synthetized for the first time in 1935 by Ferdinand Münz. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body. REFERENCES. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients. Learn systemic lupus erythematosus (SLE) symptoms (butterfly rash), treatment options, diagnosis, prognosis, causes, and pregnancy flares. Read about diet recommendations, and see pictures of the autoimmune disease. Background Cerebral sinovenous thrombosis in TEENren is a serious

3 disorder, and information is needed about its prevention and treatment. Methods The Canadian Pediatric Ischemic Stroke Registry was initiated in 1992 at the 16 pediatric tertiary care centers in Canada. Start studying Med Surg ADN. Learn vocabulary, terms, and more with flashcards, games, and other study tools. A liver panel is a group of tests performed together that may be used to screen for liver damage, especially if someone has a condition or is taking a drug that may affect the liver, or to help diagnose liver disease if a person has symptoms that indicate possible liver dysfunction. The following represent additions to UpToDate from the past six months that were considered by the editors and authors to be of particular interest. The most re lipedema, lipolymphedema, lipoedema, fat legs, big legs, liposuction for lipedema, tumescent liposuction, WAL, Stage 2 lipedema, Stage 3 lipedema, lipedema treatment, lymph-sparing liposuction, super obesity, lymphedema, morbid obesity, fat painful legs. Ed's Guide to Alternative Therapies. Contents: Acai Berries Acupuncture Artemisinin for cancer Beta-mannan to reverse dysplasia of the cervix Anti-Malignin antibody test for cancer The use of heparin and. Various methods of heparin depolymerisation are used in the manufacture of low-molecular-weight heparin low molecular weight. ICD -10 is a diagnostic coding system implemented by the World Health Organization. In this section we list out codes for anticoagulants / antithrombotics and ICD Code. Icd 10 code for bridging anticoagulant to heparin for surgery. ICD -10: Crosswalks to considers the use of lowmolecular-weight heparins Both unfractionated heparin and low-molecular-weight heparin are no ICD -9- CM code at hospitals that use a particular form of heparin,. Icd 10 subcutaneous heparin started receiving full therapeutic doses of low-molecular-weight heparin list presents a sub-set of the Read Code system. Aetna considers the use of low-molecular-weight. CPT Codes / HCPCS Codes / ICD -10 Codes; Code. Should the MUHC use low-molecular-weight heparin in inpatient. Feb 14, Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer.. The VDW records patients' diagnoses captured with International Classification of Diseases (ICD)-9 codes, health services procedure data as captured with. T45.515A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.. Adverse effect of anticoagulant; Adverse effect of enoxaparin; Adverse effect of heparin; Adverse effect of

4 warfarin ; Adverse reaction to enoxaparin; Anticoagulant adverse reaction; Heparin adverse. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention blood clots and treatment of venous thromboembolism and in the treatment of myocardial infarction. Heparin is a naturally occurring polysaccharide that inhibits coagulation, the. low molecular weight heparin, rivaroxaban was associated with a lower administration [10]. To date, eight randomized trials enrolling almost patients show that rivaroxaban is either non-inferior or superior to enoxaparin for prevent- ing venous revision (ICD-10) (post-2002) codes were in use to define baseline. Oct 14, The aim of this study was to investigate if use of LMWH is associated with a reduced risk of diagnosis of prolonged labor, after taking maternal, fetal and other.. We used the ICD-10 codes in the MBR and the coding of diagnoses was made by attendant physicians at the delivery ward or at discharge. Feb 14, Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer.. The VDW records patients' diagnoses captured with International Classification of Diseases (ICD)-9 codes, health services procedure data as captured with. Free, official coding info for 2018 ICD-10-CM Z includes detailed rules, notes, synonyms, ICD-9-CM conversion, index and annotation crosswalks, DRG grouping and more. Sep 26, Subcutaneous low-molecular weight heparin (Lovenox) may be substituted for intravenous heparin. An inferior vena cava filter may be. Chronic DVT ICD-9- CM codes were created and existing code titles were revised in 2009 to help distinguish between acute and chronic DVT. Typically, an acute DVT is. Enoxaparin. This medication prevents blood clots in patients who are on bed rest or who are having orthopedic surgery of the hip replacement, knee replacement, or large intestinal surgery. It is also used alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body. Ed's Guide to Alternative Therapies. Contents: Acai Berries Acupuncture Artemisinin for cancer Beta-mannan to reverse dysplasia of the cervix Anti-Malignin antibody test for cancer The following represent additions to UpToDate from the past six months that were considered by the

5 editors and authors to be of particular interest. The most re Ethylenediaminetetraacetic acid (EDTA), also known by several other names, is a chemical used for both industrial and medical purposes.it was synthetized for the first time in 1935 by Ferdinand Münz. Start studying Med Surg ADN. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Learn systemic lupus erythematosus (SLE) symptoms (butterfly rash), treatment options, diagnosis, prognosis, causes, and pregnancy flares. Read about diet recommendations, and see pictures of the autoimmune disease. lipedema, lipolymphedema, lipoedema, fat legs, big legs, liposuction for lipedema, tumescent liposuction, WAL, Stage 2 lipedema, Stage 3 lipedema, lipedema treatment, lymphsparing liposuction, super obesity, lymphedema, morbid obesity, fat painful legs. A liver panel is a group of tests performed together that may be used to screen for liver damage, especially if someone has a condition or is taking a drug that may affect the liver, or to help diagnose liver disease if a person has symptoms that indicate possible liver dysfunction. Background Cerebral sinovenous thrombosis in TEENren is a serious disorder, and information is needed about its prevention and treatment. Methods The Canadian Pediatric Ischemic Stroke Registry was initiated in 1992 at the 16 pediatric tertiary care centers in Canada. REFERENCES. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients. Icd 10 subcutaneous heparin started receiving full therapeutic doses of low-molecular-weight heparin list presents a sub-set of the Read Code system. The use of heparin and. Various methods of heparin depolymerisation are used in the manufacture of lowmolecular-weight heparin low molecular weight Both unfractionated heparin and low-molecular-weight heparin are no ICD -9-CM code at hospitals that use a particular form of heparin,. Aetna considers the use of lowmolecular-weight. CPT Codes / HCPCS Codes / ICD -10 Codes; Code. Should the MUHC use low-molecular-weight heparin in inpatient. ICD -10 is a diagnostic coding system implemented by the World Health Organization. In this section we list out codes for anticoagulants / antithrombotics and ICD Code. Icd 10 code for bridging anticoagulant to heparin for surgery. ICD -10: Crosswalks to considers the use of low-molecular-weight heparins. Enoxaparin. This medication prevents blood clots in patients who are on bed rest or who are having orthopedic surgery of the hip replacement, knee

6 replacement, or large intestinal surgery. It is also used alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Free, official coding info for 2018 ICD-10-CM Z includes detailed rules, notes, synonyms, ICD-9-CM conversion, index and annotation crosswalks, DRG grouping and more. Feb 14, Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer.. The VDW records patients' diagnoses captured with International Classification of Diseases (ICD)-9 codes, health services procedure data as captured with. Feb 14, Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer.. The VDW records patients' diagnoses captured with International Classification of Diseases (ICD)-9 codes, health services procedure data as captured with. T45.515A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.. Adverse effect of anticoagulant; Adverse effect of enoxaparin; Adverse effect of heparin; Adverse effect of warfarin ; Adverse reaction to enoxaparin; Anticoagulant adverse reaction; Heparin adverse. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention blood clots and treatment of venous thromboembolism and in the treatment of myocardial infarction. Heparin is a naturally occurring polysaccharide that inhibits coagulation, the. Oct 14, The aim of this study was to investigate if use of LMWH is associated with a reduced risk of diagnosis of prolonged labor, after taking maternal, fetal and other.. We used the ICD-10 codes in the MBR and the coding of diagnoses was made by attendant physicians at the delivery ward or at discharge. Sep 26, Subcutaneous low-molecular weight heparin (Lovenox) may be substituted for intravenous heparin. An inferior vena cava filter may be. Chronic DVT ICD-9- CM codes were created and existing code titles were revised in 2009 to help distinguish between acute and chronic DVT. Typically, an acute DVT is. low molecular weight heparin, rivaroxaban was associated with a lower administration [10]. To date, eight randomized trials enrolling almost patients show that rivaroxaban is either non-inferior or superior to enoxaparin for prevent- ing venous revision (ICD-10) (post-2002) codes were in use to define baseline. Start studying Med Surg ADN. Learn vocabulary, terms, and more with flashcards, games, and other study tools.

7 Ethylenediaminetetraacetic acid (EDTA), also known by several other names, is a chemical used for both industrial and medical purposes.it was synthetized for the first time in 1935 by Ferdinand Münz. REFERENCES. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients. Background Cerebral sinovenous thrombosis in TEENren is a serious disorder, and information is needed about its prevention and treatment. Methods The Canadian Pediatric Ischemic Stroke Registry was initiated in 1992 at the 16 pediatric tertiary care centers in Canada. lipedema, lipolymphedema, lipoedema, fat legs, big legs, liposuction for lipedema, tumescent liposuction, WAL, Stage 2 lipedema, Stage 3 lipedema, lipedema treatment, lymph-sparing liposuction, super obesity, lymphedema, morbid obesity, fat painful legs. Learn systemic lupus erythematosus (SLE) symptoms (butterfly rash), treatment options, diagnosis, prognosis, causes, and pregnancy flares. Read about diet recommendations, and see pictures of the autoimmune disease. A liver panel is a group of tests performed together that may be used to screen for liver damage, especially if someone has a condition or is taking a drug that may affect the liver, or to help diagnose liver disease if a person has symptoms that indicate possible liver dysfunction. The following represent additions to UpToDate from the past six months that were considered by the editors and authors to be of particular interest. The most re Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body. Ed's Guide to Alternative Therapies. Contents: Acai Berries Acupuncture Artemisinin for cancer Beta-mannan to reverse dysplasia of the cervix Anti-Malignin antibody test for cancer Contact Information Telephone or BORG (2674) FAX Postal address Minnetonka Industrial Rd. Minnetonka, MN Electronic mail General Information: gm financial loss payee address

8 Halo school agenda Sitemap Thursday, July 29, 1999 This Site Has Been Visited Times.

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Fragmin) Reference Number: CP.PHAR.225 Effective Date: 05.01.16 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Coding Implications Revision Log See Important Reminder

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Arixtra) Reference Number: CP.PHAR.226 Effective Date: 07.01.18 Last Review Date: 02.18 Line of Business: Oregon Health Plan Coding Implications Revision Log See Important Reminder at

More information

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2 News Release Bayer HealthCare AG Corporate Communications 51368 Leverkusen Germany Phone +49 214 30 1 www.news.bayer.com Venous Blood Clot Prevention after Hip Replacement Surgery: The Lancet Publishes

More information

ANTICOAGULANT THERAPY ANTICOAGULANT THERAPY REVISITED Thrombosis is a complication of underaggressive anticoagulant therapy

ANTICOAGULANT THERAPY ANTICOAGULANT THERAPY REVISITED Thrombosis is a complication of underaggressive anticoagulant therapy ANTICOAGULANT THERAPY REVISITED 2004 or, Which one(s) of these (#$%$#!@#^) drugs should be the one(s) I use, and for what? ANTICOAGULANT THERAPY One of most common treatments in hospital & out 2 nd most

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Arixtra) Reference Number: CP.PHAR.226 Effective Date: 05.01.16 Last Review Date: 02.19 Line of Business: Commercial, HIM-Medical Benefit, Medicaid Coding Implications Revision Log See

More information

Venous Thromboembolism Prophylaxis after Major Elective Orthopedic Surgery

Venous Thromboembolism Prophylaxis after Major Elective Orthopedic Surgery Venous Thromboembolism Prophylaxis after Major Elective Orthopedic Surgery Tony Wan, MD, FRCPC Clinical Instructor, Division of General Internal Medicine Department of Medicine, University of British Columbia

More information

Study population The study population comprised patients undergoing major hip or knee surgery.

Study population The study population comprised patients undergoing major hip or knee surgery. Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patients Dranitsaris G, Kahn S R, Stumpo C, Paton T W, Martineau J, Smith R,

More information

Research & Reviews: Journal of Hospital and Clinical Pharmacy

Research & Reviews: Journal of Hospital and Clinical Pharmacy Research & Reviews: Journal of Hospital and Clinical Pharmacy Enoxaparin Administration Times and Hospital Length of Stay in Venous Thromboembolism Treatment: A Retrospective Study Dana Huettenmoser 1#,

More information

Analysis of the Anticoagulant Market

Analysis of the Anticoagulant Market MEDICAL DEVICES PHARMACEUTICALS CHEMICALS FOOD & BEVERAGE ELECTRONICS Analysis of the Anticoagulant Market VPG Publications, Consulting, Clients www.vpgcorp.com VPG Market Research Reports www.vpgmarketresearch.com

More information

LVHN Scholarly Works. Lehigh Valley Health Network. Joseph G. Ottinger RPh, MS, MBA, BCPS Lehigh Valley Health Network,

LVHN Scholarly Works. Lehigh Valley Health Network. Joseph G. Ottinger RPh, MS, MBA, BCPS Lehigh Valley Health Network, Lehigh Valley Health Network LVHN Scholarly Works Department of Pharmacy Retrospective Evaluation of Delayed Administration of Fondaparinux in Providing Comparable Safety and Efficacy Outcomes in Patients

More information

ANTICOAGULANT THERAPY ANTICOAGULANT THERAPY REVISITED 2005

ANTICOAGULANT THERAPY ANTICOAGULANT THERAPY REVISITED 2005 ANTICOAGULANT THERAPY REVISITED 2005 or, Which one(s) of these (#$%$#!@#^) drugs should be the one(s) I use, and for what? ANTICOAGULANT THERAPY One of most common treatments in hospital & out 2 nd most

More information

ANTICOAGULANT THERAPY REVISITED Thrombosis is a complication of underaggressive anticoagulant therapy ANTICOAGULANT THERAPY.

ANTICOAGULANT THERAPY REVISITED Thrombosis is a complication of underaggressive anticoagulant therapy ANTICOAGULANT THERAPY. ANTICOAGULANT THERAPY REVISITED 2005 or, Which one(s) of these (#$%$#!@#^) drugs should be the one(s) I use, and for what? ANTICOAGULANT THERAPY Goals of Therapy PREVENTION OF THROMBOEMBOLISM!!! Stop propagation

More information

Bayer R&D Investor Day 2005

Bayer R&D Investor Day 2005 Science For A Better Life HealthCare Bayer R&D Investor 25 December 8, 25 London Bayer R&D Investor 25 BAY 59-7939: A Novel, ral, Direct Factor Xa Inhibitor Frank Misselwitz Head of Therapeutic Area Cardiovascular,

More information

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy ~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 1 of 4 Session 1 Topics Review of coagulation and the vascular phase of hemostasis Unfractionated heparin Low molecular

More information

A Pilot Study Comparing Hospital Readmission Rates In Patients Receiving Rivaroxaban or Enoxaparin After Orthopedic Surgery

A Pilot Study Comparing Hospital Readmission Rates In Patients Receiving Rivaroxaban or Enoxaparin After Orthopedic Surgery A Pilot Study Comparing Hospital Readmission Rates In Patients Receiving Rivaroxaban or Enoxaparin After Orthopedic Surgery Melissa A. Herschman, PharmD, BCPS; Frank S. Rigelsky, PharmD, BCPS; and Sandra

More information

Dr. Andrew Kotaska YELLOWKNIFE NT 221 VENOUS THROMBOEMBOLISM PROPHYLAXIS: WHO REALLY NEEDS SNAKE OIL?

Dr. Andrew Kotaska YELLOWKNIFE NT 221 VENOUS THROMBOEMBOLISM PROPHYLAXIS: WHO REALLY NEEDS SNAKE OIL? Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 Dr. Andrew Kotaska YELLOWKNIFE NT 221 VENOUS THROMBOEMBOLISM PROPHYLAXIS:

More information

SYNOPSIS. Clinical Study Report for Study CV Individual Study Table Referring to the Dossier

SYNOPSIS. Clinical Study Report for Study CV Individual Study Table Referring to the Dossier Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Individual Study Table Referring to the Dossier (For National Authority Use Only) Name of Active Ingredient: SYNOPSIS Clinical Study

More information

Learning Objectives include:

Learning Objectives include: Organization Frederick Memorial Hospital Solution Title Using Lean to Improve Quality Outcomes DVT Case Study Program/Project Description, including Goals: Hospital Acquired DVTs have become a very serious

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium fondaparinux, 2.5mg/0.5ml, solution for injection (Arixtra ) No. (287/06) GlaxoSmithKline 7 July 2006 The Scottish Medicines Consortium has completed its assessment of the

More information

Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle

Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle Haematology Acute Date Uploaded:

More information

UvA-DARE (Digital Academic Repository) Factor XI as target for antithrombotic therapy van Montfoort, M.L. Link to publication

UvA-DARE (Digital Academic Repository) Factor XI as target for antithrombotic therapy van Montfoort, M.L. Link to publication UvA-DARE (Digital Academic Repository) Factor XI as target for antithrombotic therapy van Montfoort, M.L. Link to publication Citation for published version (APA): van Montfoort, M. L. (2014). Factor XI

More information

TSOAC Case Study 1. Question. TSOAC Case Study 1 Continued

TSOAC Case Study 1. Question. TSOAC Case Study 1 Continued TSOAC Case Study 1 An otherwise healthy 56-year-old man presents to the emergency department with left leg pain and swelling for the last 3 days. Compression ultrasonography confirms left common femoral

More information

Enoxaparin 1 mg/kg twice daily as a bridge to

Enoxaparin 1 mg/kg twice daily as a bridge to Once Daily Enoxaparin for Outpatient Treatment of Acute Venous Thromboembolism: A Case-control Study Clinical and Applied Thrombosis/Hemostasis Volume 16 Number 1 January/February 2010 21-25 # 2010 The

More information

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof 2 Lina Al-Lawama Rama Al-Ashqar Malik Al-Zohlof Anticoagulant drugs Recap Last lecture we were talking about antiplatelet drugs, we mentioned 5 drugs : Aspirin which is used alone with patents that have

More information

Continuing Education for Pharmacists

Continuing Education for Pharmacists Continuing Education for Pharmacists Oral anticoagulation without protimes: A review of two emerging agents that may come to market. Lindsay Davis, Pharm.D. (Acute Care Pharmacy Resident, Phoenix VA Medical

More information

Managing the Risks Associated with Anticoagulant Therapy. Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde

Managing the Risks Associated with Anticoagulant Therapy. Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde Managing the Risks Associated with Anticoagulant Therapy Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde Background Identified as high risk medicines Wide range

More information

Clexane pre-filled syringes 150mg/ml in syringe sizes equating to the following doses: 120mg and 150mg. Page 1 of 8

Clexane pre-filled syringes 150mg/ml in syringe sizes equating to the following doses: 120mg and 150mg. Page 1 of 8 Low Molecular Weight Heparins (LMWH) Shared Care Guideline for the use of Enoxaparin and Dalteparin in the Treatment and Prophylaxis of Venous Thromboembolism Introduction Low Molecular Weight Heparins

More information

Hemostasis/Thrombosis IV

Hemostasis/Thrombosis IV Hemostasis/Thrombosis IV Antithrombotic Therapy Antithrombotic Therapy Mainstay of battle against thromboembolic disease Hot area of new drug research Cannot inhibit clot formation without increased risk

More information

New Insights into the Diagnosis & Management of Venous Thromboembolism (VTE) Michael Miller, M.D.

New Insights into the Diagnosis & Management of Venous Thromboembolism (VTE) Michael Miller, M.D. New Insights into the Diagnosis & Management of Venous Thromboembolism (VTE) Michael Miller, M.D. Professor of Cardiovascular Medicine University of Maryland School of Medicine Copyright A.P. Wheeler 2009

More information

iccnet CHSA Clinical Protocol - HEPARIN

iccnet CHSA Clinical Protocol - HEPARIN Name: iccnet CHSA Clinical Protocol - HEPARIN This clinical guideline or clinical protocol is based on a review of best practice evidence and expert opinion. It is intended to guide practice and does not

More information

Anticoagulation in VTE The Haematologist s Perspective. Dr. M.D. Maina FRCP Edin.

Anticoagulation in VTE The Haematologist s Perspective. Dr. M.D. Maina FRCP Edin. Anticoagulation in VTE The Haematologist s Perspective Dr. M.D. Maina FRCP Edin. Disclosures None The coagulation process that leads to haemostasis involves a complex set of reactions involving approximately

More information

Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research Hospital in Turkey

Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research Hospital in Turkey VOLUME 8 NUMBER 3 September 2017 JOURNAL OF CLINICAL AND EXPERIMENTAL INVESTIGATIONS ORIGINAL ARTICLE Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website or on the website www.clinicalstudyresults.org hosted by the Pharmaceutical Research and

More information

UW Medicine Alternative Monitoring for Antithrombotic Agents

UW Medicine Alternative Monitoring for Antithrombotic Agents Tags: monitoring alternative monitoring SUMMARY OF ANTICOAGULATION LAB TESTS AT UWMedicine Description Order Code Specimen Collection Availability Turn-Around Time Anti Xa Based Tests antixa for heparin

More information

Lovenox weight calculator

Lovenox weight calculator P ford residence southampton, ny Lovenox weight calculator What Are the Treatments for Hemangioma on the Liver? Sciatic Nerve Surgery Recovery Time. How to Determine the Best Brand of Compression Stockings

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium fondaparinux sodium, 2.5mg/0.5ml solution for injection, pre-filled syringe (Arixtra ) No. (420/07) GlaxoSmithKline 09 November 2007 The Scottish Medicines Consortium has

More information

Personal Disclosure. The Coagulation Cascade. Learning Objectives. Unfractionated Heparin (UFH): Mechanism of Action. Heparin: Mechanism of Action

Personal Disclosure. The Coagulation Cascade. Learning Objectives. Unfractionated Heparin (UFH): Mechanism of Action. Heparin: Mechanism of Action Personal Disclosure Heparin/Low Molecular Weight Heparin and Fondaparinux Pharmacology and Pharmacotherapy Mary Jane E. Mattern PharmD Pharmacist William W. Backus Hospital There are no actual or potential

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website or on the website www.clinicalstudyresults.org hosted by the Pharmaceutical Research and

More information

Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis.

Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty Nerurkar J, Wade W E, Martin B C Record Status This is a critical abstract

More information

Direct anticoagulation therapy

Direct anticoagulation therapy Direct anticoagulation therapy Pan-Arab Meeting & Saudi Society of Hematology Dr Ihab Alhemaidi MBBS MRCP(Lond UK) FRCPath. Fellow of the Royal Society of Medicine Consultant Adult hematology/bmt Section

More information

Alex C. Spyropoulos, MD; Judith S. Hurley, MS, RD; Gabrielle N. Ciesla, MS; and Gregory de Lissovoy, PhD, MPH

Alex C. Spyropoulos, MD; Judith S. Hurley, MS, RD; Gabrielle N. Ciesla, MS; and Gregory de Lissovoy, PhD, MPH Management of Acute Proximal Deep Vein Thrombosis* Pharmacoeconomic Evaluation of Outpatient Treatment With Enoxaparin vs Inpatient Treatment With Unfractionated Heparin Alex C. Spyropoulos, MD; Judith

More information

Peer Review Report # 2. Low Molecular Weight Heparins

Peer Review Report # 2. Low Molecular Weight Heparins 20 th Expert Committee on Selection and Use of Essential Medicines Peer Review Report # 2 Low Molecular Weight Heparins (1) Does the application adequately address the issue of the public health need for

More information

CDEC FINAL RECOMMENDATION

CDEC FINAL RECOMMENDATION CDEC FINAL RECOMMENDATION APIXABAN (Eliquis Bristol-Myers Squibb Canada and Pfizer Canada) Indication: Venous Thromboembolic Events Recommendation: The Canadian Drug Expert Committee (CDEC) recommends

More information

Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis.

Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis. Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparin Bergqvist D, Lindgren B, Matzsch T Record Status This is a critical abstract

More information

Physician Orders - Adult

Physician Orders - Adult Physician Orders - Adult attach patient label here Title: Direct Thrombin Inhibitor (DTI) Protocol Orders Height: cm Weight: kg Allergies: [ ] No known allergies [ ]Medication allergy(s): [ ] Latex allergy

More information

LOW MOLECULAR WEIGHT HEPARIN THE STANDARD VALUE

LOW MOLECULAR WEIGHT HEPARIN THE STANDARD VALUE LOW MOLECULAR WEIGHT HEPARIN THE STANDARD VALUE ANASTASIOS V. KOROMPILIAS, MD ORTHOPAEDIC DEPARTMENT, MEDICAL SCHOOL UNIVERSITY OF IOANNINA, IOANNINA, GREECE MAJOR ORTHOPAEDIC SURGERY POSTOPERATIVE CLASSIFIED

More information

Antithrombotic Therapies: Parenteral Agents

Antithrombotic Therapies: Parenteral Agents Antithrombotic Therapies: Parenteral Agents Christine A. Sorkness, Pharm.D. Professor of Pharmacy & Medicine (CHS) UW School of Pharmacy Clinical Pharmacist, Anticoagulation Clinic, Wm S. Middleton VA

More information

Laboratory Monitoring of Anticoagulation

Laboratory Monitoring of Anticoagulation Michael Smith, Pharm. D., BCPS, CACP East Region Pharmacy Clinical Manager Hartford HealthCare Learning Objectives Explain the role of common laboratory tests used in monitoring of anticoagulation therapy.

More information

Page 1 of 7. Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Page 1 of 7. Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Date of submission September 2018 Date on which guideline

More information

Update on the Direct Oral Anticoagulants (DOACs)

Update on the Direct Oral Anticoagulants (DOACs) Update on the Direct Oral Anticoagulants (DOACs) J. Randle Adair DO, PhD Internal Medicine New Mexico Cancer Center & Co-Chair, Anticoagulation Subcommittee Presbyterian Healthcare Services (PHS) Attending,

More information

Annals of Internal Medicine

Annals of Internal Medicine 18 May 1999 Volume 130 Number 10 Annals of Internal Medicine Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis A Cost-Effectiveness Analysis

More information

Antithrombin Deficiency

Antithrombin Deficiency Stop the Clot TM Antithrombin Deficiency An In-Depth Guide for Patients and Health Care Providers www.stoptheclot.org AWARENESS PREVENTION TREATMENT SUPPORT NATT Mission To prevent, diagnose and treat

More information

The novel anticoagulants: entering a new era. BOUNAMEAUX, Henri. Abstract

The novel anticoagulants: entering a new era. BOUNAMEAUX, Henri. Abstract Article The novel anticoagulants: entering a new era BOUNAMEAUX, Henri Abstract During the past five decades, anticoagulant therapy has consisted of rapidly acting parenteral drugs (unfractionated heparin

More information

This paper reviews the potential cost-effectiveness

This paper reviews the potential cost-effectiveness n reports n Cost-Effectiveness of Rivaroxaban After Total Hip or Total Knee Arthroplasty Louis M. Kwong, MD, FACS Abstract Venous thromboembolism (VTE) following joint replacement surgery represents an

More information

New Anticoagulants. Kenneth A. Bauer

New Anticoagulants. Kenneth A. Bauer New Anticoagulants Kenneth A. Bauer Traditional anticoagulant drugs, including unfractionated heparin and warfarin, have several limitations. New anticoagulants have been developed that target a single

More information

Procedure for the prescribing and administration of Low Molecular Weight Heparins

Procedure for the prescribing and administration of Low Molecular Weight Heparins Procedure for the prescribing and administration of Low Molecular Weight Heparins Author: Lilian Baxendale Designation: Pharmacist Version: 1c Date: March 2013 Date Approved: 17 th May 2013 Approved By:

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) Draft

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) Draft European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 24 April 2008 EMEA/CHMP/BMWP/118264/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) Draft GUIDELINE

More information

Anticoagulation Safety

Anticoagulation Safety Anticoagulation Safety 2/12/13 Latha Sivaprasad, MD, FHM, FACP Associate Chief Medical Officer Chief Patient Experience Officer Laura O Brien RN, MA, CCRN Clinical Nurse Specialist Outline The journey

More information

HEPARIN INDUCED THROMBOCYTOPENIA. Cortney Gandy PharmD candidate 2017 University of Kentucky

HEPARIN INDUCED THROMBOCYTOPENIA. Cortney Gandy PharmD candidate 2017 University of Kentucky 1 HEPARIN INDUCED THROMBOCYTOPENIA Cortney Gandy PharmD candidate 2017 University of Kentucky 2 Objectives Be able to explain the etiology of HIT Discuss the appropriate agents when treating HIT 3 Lets

More information

Bevyxxa (betrixaban) NEW PRODUCT SLIDESHOW

Bevyxxa (betrixaban) NEW PRODUCT SLIDESHOW Bevyxxa (betrixaban) NEW PRODUCT SLIDESHOW Introduction Brand name: Bevyxxa Generic name: Betrixaban Pharmacological class: Factor Xa inhibitor Strength and Formulation: 40mg, 80mg; caps Manufacturer:

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency London, 19 March 2009 EMEA/CHMP/BMWP/118264/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON NON-CLINICAL AND CLINICAL DEVELOPMENT OF SIMILAR BIOLOGICAL

More information

Enoxaparin sodium 150mg (equivalent to 15,000 IU anti-xa. activity) in 0.2ml water for injections. activity) in 0.4ml water for injections

Enoxaparin sodium 150mg (equivalent to 15,000 IU anti-xa. activity) in 0.2ml water for injections. activity) in 0.4ml water for injections 1. NAME OF THE MEDICINAL PRODUCT Clexane (Lovenox) Syringes Clexane (Lovenox) Forte Syringes 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Clexane (Lovenox) Syringes (100mg/ml) 20mg Injection 40mg Injection

More information

DRUG NAME : Clexane (enoxaparin) Pre-Filled Syringes

DRUG NAME : Clexane (enoxaparin) Pre-Filled Syringes NHS ONEL & Barking, Havering & Redbridge University Hospitals Trust Shared Care Guidelines DRUG NAME : Clexane (enoxaparin) Pre-Filled Syringes DOCUMENT TO BE SCANNED INTO ELECTRONIC RECORDS AS AND FILED

More information

PROPHYLAXIS IN THE ORTHOPEDIC PATIENT: Martin H. Ellis MD Hematology Institute and Blood Bank Meir Medical Center Kfar Saba

PROPHYLAXIS IN THE ORTHOPEDIC PATIENT: Martin H. Ellis MD Hematology Institute and Blood Bank Meir Medical Center Kfar Saba VENOUS THROMBOEMBOLISM PROPHYLAXIS IN THE ORTHOPEDIC PATIENT: Martin H. Ellis MD Hematology Institute and Blood Bank Meir Medical Center Kfar Saba OVERVIEW Biochemistry of coagulation Pathogenesis of VTE

More information

Acute STEMI in patients 75 years of age. 150 mg/ml concentration (3.2):

Acute STEMI in patients 75 years of age. 150 mg/ml concentration (3.2): HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use safely and effectively. See full prescribing information for. sodium injection for subcutaneous and

More information

Anti- THrombosis with Enoxaparin in intubated Adolescents

Anti- THrombosis with Enoxaparin in intubated Adolescents Anti- THrombosis with Enoxaparin in intubated Adolescents E. Vincent S. Faustino, MD, MHS October 2017 NHLBI submission S L I D E 0 Research question, central hypothesis and primary aim Research Question

More information

Platelet Factor IV- Heparin Antibodies. Presenter: Michael J. Warhol, M.D.

Platelet Factor IV- Heparin Antibodies. Presenter: Michael J. Warhol, M.D. Platelet Factor IV- Heparin Antibodies Presenter: Michael J. Warhol, M.D. Learning Objectives Describe the mechanism of interaction between Heparin and Platelet Factor 4 Review the chemistry of Heparin

More information

Consulted With; Post/Committee/Group Date Haematology Dr Shereen Elshazly (Lead for Anticoagulation) January 2016 Department of Anaesthesia

Consulted With; Post/Committee/Group Date Haematology Dr Shereen Elshazly (Lead for Anticoagulation) January 2016 Department of Anaesthesia Peri-procedural anticoagulation in Adult patients taking Warfarin and novel oral anti-coagulants (NOACS) Clinical Guideline Register No: 16005 Status: Public Developed in response to: Contributes to CQC

More information

SNF REPORT NO. 13/03. Cost-Effectiveness of Fondaparinux vs Enoxaparin as Venous Thromboembolism Prophylaxis in Norway

SNF REPORT NO. 13/03. Cost-Effectiveness of Fondaparinux vs Enoxaparin as Venous Thromboembolism Prophylaxis in Norway SNF REPORT NO. 13/03 Cost-Effectiveness of Fondaparinux vs Enoxaparin as Venous Thromboembolism Prophylaxis in Norway by Afsane Bjorvatn Frode Kristiansen SNF-Project No. 2725 Cost-Effectiveness of Fondaparinux

More information

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects. Heparin Induced Eric Kraut, MD Professor of Internal Medicine The Ohio State University Medical Center Heparin Induced Heparin induced thrombocytopenia occurs in up to 5 % of patients receiving unfractionated

More information

DRUGDEX DRUG EVALUATIONS. This volume has expired. Product will stop functioning in 13 days. Install the current volume now.

DRUGDEX DRUG EVALUATIONS. This volume has expired. Product will stop functioning in 13 days. Install the current volume now. DRUGDEX DRUG EVALUATIONS This volume has expired. Product will stop functioning in 13 days. Install the current volume now. CLINICAL APPLICATIONS ENOXAPARIN COMPARATIVE EFFICACY / EVALUATION WITH OTHER

More information

Hematology Emergencies: Problems with Platelets

Hematology Emergencies: Problems with Platelets Hematology Emergencies: Problems with Platelets Christian Cable, MD, FACP Associate Professor of Medicine Division of Hematology & Oncology Texas A&M HSC College of Medicine Scott & White Healthcare Fundamentals

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 3.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure ID#: SCIP- Performance

More information

HIGHLIGHTS OF PRESCRIBING INFORMATION

HIGHLIGHTS OF PRESCRIBING INFORMATION HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ENOXAPARIN SODIUM INJECTION safely and effectively. See full prescribing information for ENOXAPARIN

More information

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin Coordinated Primary Options Service DVT Management Plan Management options using Dabigatran or Warfarin Name NHI DOB Ethnicity Gender Address Contact Information Mobile Home Treatment commenced date *CPO

More information

Disclosures. The Yin and Yang of Clotting and Anticoagulation: VTE Management in A New JCAHO Era. Objectives

Disclosures. The Yin and Yang of Clotting and Anticoagulation: VTE Management in A New JCAHO Era. Objectives The Yin and Yang of Clotting and Anticoagulation: VTE Management in A New JCAHO Era Kathryn Hassell, M.D. Professor of Medicine Division of Hematology University of Colorado Denver Health Sciences Center

More information

ENCLEX Injection (Enoxaparin)

ENCLEX Injection (Enoxaparin) Published on: 10 Jul 2014 ENCLEX Injection () Black Box Warning: Spinal/epidural Hematomas Epidural or spinal hematomas may occur in patients who are anticoagulated with lowmolecular weight heparins or

More information

General News. Product Notes. Instrument Notice HELENA SALES FORCE TO: FROM: SUBJECT: HELENA POINT OF CARE ROUND-UP/US DOMESTIC DATE: 9/1/2009

General News. Product Notes. Instrument Notice HELENA SALES FORCE TO: FROM: SUBJECT: HELENA POINT OF CARE ROUND-UP/US DOMESTIC DATE: 9/1/2009 TO: FROM: SUBJECT: HELENA SALES FORCE DATE: 9/1/2009 General News HELENA POINT OF CARE ROUND-UP/US DOMESTIC We have concluded a very large meeting with the AACC in Chicago. The leads have been processed

More information

Acute STEMI in patients 75 years of age. 30 mg single IV bolus plus a 1 mg/kg SC dose followed by 1 mg/kg SC every 12 hours with aspirin)

Acute STEMI in patients 75 years of age. 30 mg single IV bolus plus a 1 mg/kg SC dose followed by 1 mg/kg SC every 12 hours with aspirin) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use enoxaparin sodium injection safely and effectively. See full prescribing information for enoxaparin

More information

3 : 34. Pankaj Manoria, P C Manoria, Bhopal

3 : 34. Pankaj Manoria, P C Manoria, Bhopal 3 : 34 Newer Antithrombins and anticoagulants Introduction Thrombosis is a leading cause of morbidity and mortality but for decades, anticoagulant therapy has usually consisted of unfractionate heparin

More information

Venous thromboembolism Algorithm A: Evidence of an ICD-9-CM code used to define VTE in the Inpatient care setting in any diagnosis position.

Venous thromboembolism Algorithm A: Evidence of an ICD-9-CM code used to define VTE in the Inpatient care setting in any diagnosis position. Disclaimer The FDA chose a specific outcome algorithm that met its need for a given medical product-outcome assessment. The use of a specific outcome algorithm in a Sentinel assessment should not be interpreted

More information

Art by C. Michael Gibson, MS, MD

Art by C. Michael Gibson, MS, MD P o rto l a 2 0 14 the art of science for the benefit of patients Art by C. Michael Gibson, MS, MD creating innovation. breakthrough medicines. value. creating a growth company 100+ strong Portola Pharmaceuticals

More information

Acute STEMI in patients <75 years of age [For dosing in subsequent PCI, see Dosage and Administration (2.1)]

Acute STEMI in patients <75 years of age [For dosing in subsequent PCI, see Dosage and Administration (2.1)] HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Enoxaparin sodium injection safely and effectively. See full prescribing information for Enoxaparin

More information

EDUCATIONAL COMMENTARY D-DIMER UPDATE

EDUCATIONAL COMMENTARY D-DIMER UPDATE EDUCATIONAL COMMENTARY D-DIMER UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits see the Continuing

More information

DOAC s and Implications on Laboratory Results. Kandice Kottke-Marchant, MD, PhD Cleveland Clinic

DOAC s and Implications on Laboratory Results. Kandice Kottke-Marchant, MD, PhD Cleveland Clinic DOAC s and Implications on Laboratory Results Kandice Kottke-Marchant, MD, PhD Cleveland Clinic Anticoagulants Heparin Low Molecular Weight Heparins enoxaparin, fragmin Heparin pentasaccharide - fondaparinux

More information

DOACs Can Be Reversed!

DOACs Can Be Reversed! 1 DOACs Can Be Reversed! AC Forum 14 th National Conference April 21, 2017 Adam Cuker, MD, MS Perelman School of Medicine University of Pennsylvania 2 Full disclosures (last 12 months) Research support

More information

Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity

Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity Abhishek Gulati What is enoxaparin? Low molecular weight heparin anticoagulant Used to minimise the

More information

Heparin-Induced Thrombocytopenia and New Anticoagulants

Heparin-Induced Thrombocytopenia and New Anticoagulants Heparin-Induced Thrombocytopenia and New Anticoagulants September 2004 Elizabeth M. Van Cott, MD Massachusetts General Hospital Boston MA College of American Pathologists 2004. Materials are used with

More information

Molecular Diagnostics. Castle Medical LLC.

Molecular Diagnostics. Castle Medical LLC. Molecular Diagnostics Castle Medical LLC. What is DNA testing? Pharmacogenomics is a scientific disciple that deals with the influence of patient s genotype on drug response. Objective: to deliver the

More information

Mark Crowther, MD, MSc, FRCPC. Co-authors. Professor of Medicine, McMaster University, Canada

Mark Crowther, MD, MSc, FRCPC. Co-authors. Professor of Medicine, McMaster University, Canada Reversal of Enoxaparin-Induced Anticoagulation in Healthy Subjects by Andexanet Alfa (PRT064445), An Antidote for Direct and Indirect fxa Inhibitors A Phase 2 Randomized, Double-Blind, Placebo Controlled

More information

ENOXAPARIN AHFS??? Class: Low molecular weight heparin (LMWH).

ENOXAPARIN AHFS??? Class: Low molecular weight heparin (LMWH). ENOXAPARIN AHFS??? Class: Low molecular weight heparin (LMWH). Indications: Prevention and treatment of deep vein thrombosis, pulmonary embolism, thrombophlebitis migrans, disseminated intravascular coagulation

More information

If not heparin for bypass then what? Dr Tony Moriarty Consultant Cardiac Anaesthetist Birmingham United Kingdom

If not heparin for bypass then what? Dr Tony Moriarty Consultant Cardiac Anaesthetist Birmingham United Kingdom If not heparin for bypass then what? Dr Tony Moriarty Consultant Cardiac Anaesthetist Birmingham United Kingdom Heparin Discovered 1916, commercial available 1935 Heparin Is there an alternative, not really

More information

Omar A. Elkashef, MD

Omar A. Elkashef, MD DVT Prophylaxis in Orthopedic Surgery By Omar A. Elkashef, MD Kasr Al- aini About VTE Venous thromboembolism encompasses deep vein thrombosis (DVT) and pulmonary embolism VTE is common and PE is a potentially

More information

Drugs used in Thromboembolic Disease. Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014

Drugs used in Thromboembolic Disease. Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014 Drugs used in Thromboembolic Disease Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014 Drugs used in Thromboembolic Disease Anticoagulants: Heparin. Oral anticoagulants.

More information

Clinical Study Synopsis for Public Disclosure

Clinical Study Synopsis for Public Disclosure abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis - which is part of

More information

Acknowledgements. Expert Panel. Medication Safety Support Service (MSSS) Advisory Group. Why Anticoagulant Safety? Anticoagulation Principles

Acknowledgements. Expert Panel. Medication Safety Support Service (MSSS) Advisory Group. Why Anticoagulant Safety? Anticoagulation Principles Ontario Medication Safety Support Service Anticoagulant Project Co-leads: Acknowledgements Carmine Stumpo, Toronto East General Hospital Kris Wichman, ISMP Canada Donna Walsh, ISMP Canada Funded by the

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 3.2 NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure I#: SCIP- Performance Measure

More information

Writing Your Phase II SBIR Commercialization Plan

Writing Your Phase II SBIR Commercialization Plan Writing Your Phase II SBIR Commercialization Plan Gary Robinson, Ph.D., S.M. Business Development Adviser Office of Translational Alliances and Coordination National Heart, Lung, and Blood Institute 17

More information

ISIS PHARMACEUTICALS. ISIS-FXI Rx Program Update. Webcast December 8, 2014

ISIS PHARMACEUTICALS. ISIS-FXI Rx Program Update. Webcast December 8, 2014 ISIS PHARMACEUTICALS ISIS-FXI Rx Program Update Webcast December 8, 2014 Introduction Stan Crooke, M.D., Ph.D. CEO and Chairman, Isis Pharmaceuticals 2 Forward Looking Language Statement This presentation

More information